Showing results (341-350 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|July 15, 2026
Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-ProstateMartin W Schoen, Jiannong Li, Sihang Zeng, et al.
JCO Precision Oncology|July 15, 2026
EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung CancerWilldragon Wang, Dylan G Scholes, Alex C Watts, et al.
JCO Precision Oncology|July 23, 2026
Prognostic Significance of Cell-Free DNA Derived 5-Hydroxymethylcytosine Signatures in Newly Diagnosed Multiple MyelomaZhou Zhang, Benjamin Derman, Bei Wang, et al.
JCO Precision Oncology|July 23, 2026
Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and MonitoringFrancesca Lessi, Mariangela Morelli, Alessandro Di Gangi, et al.
JCO Precision Oncology|July 29, 2026
Pre- and Post-Treatment Predictive Models of Peritoneal Recurrence After Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel-Chemotherapy and Surgery: An International StudyMargaret M Lee, Darren J Wong, Katheryn Hall, et al.
JCO Precision Oncology|August 4, 2026
Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic CholangiocarcinomaRachel N Harvey, Rebecca Gelfer, Esther Drill, et al.
JCO Precision Oncology|August 12, 2026
Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer CenterGiulia Maddalena, Valentina Angerilli, Federico Nichetti, et al.
JCO Precision Oncology|August 26, 2026
Age-Specific Ovarian Cancer Risk Among Individuals With Pathogenic Variants in PALB2Koki Takabatake, Nicolas Kubista, Maria Sol Rosito, et al.
JCO Precision Oncology|August 26, 2026
Genomic Landscape of Early-Onset Colorectal Cancer: A Comparative Analysis With Average-Onset Metastatic Colorectal Cancer in a Real-World NGS CohortJi Eun Shin, Eunbyeol Lee, Sang Yun Ha, et al.
JCO Precision Oncology|May 29, 2025
Sequential Antibody-Drug Conjugate Therapy in Patients With Metastatic Breast Cancer Treated With Sacituzumab Govitecan and Trastuzumab DeruxtecanNicholas Mai, Miriam M Klar Lieberman, Emanuela Ferraro, et al.
Pageof 140